NICE rules out cannabis product on prescription in UK

The cannabis-based drug initially approved for use on the NHS in Wales should not be made available on prescription to treat muscle spasms in MS patients, according to NICE guidance.

Cannabis: NHS use of oral spray ruled out by NICE
Cannabis: NHS use of oral spray ruled out by NICE

In its updated guidance for treating MS released on Wednesday, NICE said the drug nabiximols (Sativex), an oral spray derived from the class B drug, was ‘not a cost effective treatment’ and clinicians should not offer it to patients.

The decision comes just two months after the drug was approved for use on the NHS in Wales. The NICE guidance overrules this recommendation, meaning new patients across the UK, including Wales, will not be able to receive the drug on the NHS.

The recommendation does not apply to any patients who may have already started treatment with Sativex, who should be able to continue treatment ‘until they and their NHS clinician think it appropriate to stop’, according to the guidance.

NICE recommends baclofen or gabapentin as first-line options to treat muscle spasms in MS patients, or a combination of the two treatments depending on a case-by-case basis. Tizandine and dantrolene were recommended as second-line options.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Social distancing should be cut to 1m in practices, says new IPC guidance

Social distancing should be cut to 1m in practices, says new IPC guidance

Practices can reduce social distancing from 2m to 1m providing the continued use...

Working as a full-time GP in clinical practice is becoming unsafe, RCGP chair warns

Working as a full-time GP in clinical practice is becoming unsafe, RCGP chair warns

The government needs to understand that general practice is a 'safety critical occupation'...

Face-to-face care debate 'too polarised', says NHS England's top GP

Face-to-face care debate 'too polarised', says NHS England's top GP

The face-to-face care debate has become 'too polarised', NHS England's top GP has...

GPs can apply learning from COVID-19 pandemic to fight climate emergency

GPs can apply learning from COVID-19 pandemic to fight climate emergency

GPs can apply learning from the COVID-19 response to help fight the climate emergency...

GP who lost her job to long COVID urges doctors not to underestimate the condition

GP who lost her job to long COVID urges doctors not to underestimate the condition

A GP with long COVID has urged other doctors to listen to patients who have the illness...

GPs must demand strong voice in COVID-19 public inquiry

GPs must demand strong voice in COVID-19 public inquiry

General practice must ensure its voice is heard as national inquiries into the initial...